IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Clear Harbor Asset Management LLC

Clear Harbor Asset Management LLC raised its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 2.7% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 8,020 shares of the company’s stock after purchasing an additional 212 shares during the period. Clear Harbor Asset Management LLC’s holdings in IDEXX Laboratories were worth $4,052,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the stock. Crewe Advisors LLC purchased a new position in IDEXX Laboratories during the 1st quarter worth $26,000. Ridgewood Investments LLC purchased a new position in shares of IDEXX Laboratories during the second quarter worth about $27,000. Institutional & Family Asset Management LLC acquired a new position in IDEXX Laboratories in the 2nd quarter valued at about $28,000. Mowery & Schoenfeld Wealth Management LLC raised its stake in IDEXX Laboratories by 750.0% during the 3rd quarter. Mowery & Schoenfeld Wealth Management LLC now owns 68 shares of the company’s stock valued at $34,000 after acquiring an additional 60 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in IDEXX Laboratories during the 2nd quarter worth approximately $36,000. Institutional investors and hedge funds own 87.84% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on IDXX. StockNews.com lowered IDEXX Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, July 10th. BTIG Research initiated coverage on shares of IDEXX Laboratories in a research note on Thursday, July 25th. They issued a “buy” rating and a $580.00 price objective on the stock. Stifel Nicolaus cut their price objective on shares of IDEXX Laboratories from $510.00 to $500.00 and set a “hold” rating for the company in a research report on Thursday, October 10th. Piper Sandler lowered their target price on shares of IDEXX Laboratories from $600.00 to $520.00 and set a “neutral” rating on the stock in a report on Wednesday, August 14th. Finally, JPMorgan Chase & Co. cut their price target on shares of IDEXX Laboratories from $630.00 to $575.00 and set an “overweight” rating for the company in a report on Friday, October 11th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $574.13.

IDEXX Laboratories Stock Performance

NASDAQ:IDXX opened at $451.41 on Friday. The firm’s fifty day simple moving average is $484.62 and its 200-day simple moving average is $489.32. The company has a quick ratio of 1.03, a current ratio of 1.37 and a debt-to-equity ratio of 0.33. The stock has a market cap of $37.16 billion, a PE ratio of 44.69, a price-to-earnings-growth ratio of 4.03 and a beta of 1.33. IDEXX Laboratories, Inc. has a fifty-two week low of $372.50 and a fifty-two week high of $583.39.

IDEXX Laboratories (NASDAQ:IDXX) last issued its earnings results on Tuesday, August 6th. The company reported $2.44 earnings per share for the quarter, missing the consensus estimate of $2.88 by ($0.44). IDEXX Laboratories had a return on equity of 57.03% and a net margin of 22.34%. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $1.01 billion. During the same quarter in the previous year, the company posted $2.67 earnings per share. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. Analysts expect that IDEXX Laboratories, Inc. will post 10.44 earnings per share for the current fiscal year.

IDEXX Laboratories Company Profile

IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.